Clinical Lung Cancer
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.9 | Q2 | 64.3% | 1.362 | Q1 | 90.5% |
| 2024 | 3.3 | Q2 | 62.6% | 1.515 | Q1 | 92.4% |
| 2023 | 3.3 | Q2 | 60.7% | 1.263 | Q1 | 90.2% |
| 2022 | 3.6 | Q2 | 54.5% | 1.137 | Q1 | 89.0% |
| 2021 | 4.8 | Q2 | 64.3% | 1.202 | Q1 | 90.0% |
| 2020 | — | — | 1.506 | Q1 | 92.4% | |
| 2019 | — | — | 1.407 | Q1 | 91.8% | |
| 2018 | — | — | 1.408 | Q1 | 90.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1525-7304
ISSN
1938-0690
region
Northern America
coverage
2000-2026